protein
| proteins involved in the biogenesis of snRNPs |
|
survival of motor neuron protein interacting protein 1, SIP1 ( |
|
B-cell CLL/lymphoma 2, BCL2 ( |
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 20, DDX20 (GEMIN3) ( |
|
STRAP to influencing intracellular localization of SMN1 |
|
SIN3A by its SIN3A-interacting domain to the exon 6 region |
|
IGF2 more than IGF1 |
|
FZD8 and LRP6 |
|
DNA transactivator FUSE binding protein, FBP ( |
|
small nuclear ribonucleoprotein polypeptides B,-D1, and -D3 |
|
LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae), LSM4 |
|
LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae), LSM6 |
|
GAR1 (SMN1 interaction requires the arginine- and glycine-rich domains of both fibrillarin and GAR1 and is defective in SMN mutants found in some SMA patients) ( |
|
osteoclast stimulating factor 1, OSTF1 |
|
zinc finger protein ZPR1 |
|
hnRNP Q proteins |
|
hnRNP-R and gry-rbp/hnRNP-Q ( |
|
coilin, COIL ( |
|
gem (nuclear organelle) associated protein 4, GEMIN4 |
|
gem (nuclear organelle) associated protein 5, GEMIN5 ( |
|
gem (nuclear organelle) associated protein 6, GEMIN6 ( |
|
gem (nuclear organelle) associated protein 7, GEMIN7 ( |
|
snurportin1, SNUPN and karyopherin (importin) beta 1, KPNB1 |
|
tumor suppressor protein p53, ( |
|
TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa, TAF4 |
|
protein phosphatase 4 (formerly X), catalytic subunit, PPP4C ( |
|
processing of precursor 7, ribonuclease P/MRP subunit (S. cerevisiae), POP7 ( |
|
transcription corepressor mSin3A ( |
|
profilin 1, PFN1 |
|
Lsm10 and Lsm11 ( |
|
fragile X mental retardation 1, FMR1 |
|
plastin 3, PLS3. Overexpression of PLS3 rescued the axon length and outgrowth defects associated with SMN down-regulation in motor neurons of SMA mouse embryos and in zebrafish |
|
physically interacted with FZD8, and a Wnt co-receptor, LRP6, and inhibited the binding of WNT3A to FZD8 and LRP6 |
|
ELAVL4 interacts with SMN1 and can rescue spinal muscular atrophy-like neuronal defects |
|
SMN1 is a novel target of ELK1, and the ETS motifs in the SMN1 promoter are involved in this regulation |
|
GEMIN2 ( |
|
is directly interacting with profilin2a (PFN2 binds to a stretch of proline residues in SMN, which is heavily impaired by a novel SMN2 missense mutation) |
|
interferes with the ROCK pathway via PFN2, providing a mechanistic basis to explain axonal defects in SMA pathogenesis |
|
differentially inhibits angiogenesis induced by distinct growth factor signaling pathways as IGFBP4 inhibited FGF2- and IGF1-stimulated angiogenesis |
|
SOX9 is a transcriptional regulator of IGFBP4 and SOX9-induced activation of IGFBP4 may be one of the mechanisms by which SOX9 suppresses cell proliferation and progression of colon cancer |
|
PAPPA cleaves IGF binding protein IGFBP4 and IGFBP5 |
|
COPA is a SMN1-binding partner, implicating this protein complex in normal SMN1 function, and this interaction serves an important function in the growth and maintenance of motor neuron processes and may play a significant role in the pathogenesis of SMA |
|
HNRNPM promotes exon 7 inclusion of SMN1 and SMN2 pre-mRNA through targeting an enhancer on exon 7 through recruiting U2AF2 |